Fluvastatin Sodium
Product Images NDC 68151-1326

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Fluvastatin Sodium (NDC 68151-1326). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label Image (68151 1326)

Label Image (68151 1326)
This is a medication called Fluvastatin, produced by Mylan. It is a 20mg capsule with lot number 3045105 and an expiration date of 08/14. The prescription was dispensed on PDM number 1326 and is only available with a prescription.*
FDA Label Image

Fluvastatin Structural Formula (7f4945a8 B0a0 41ec 984c E2a34812bb8b 01)

Fluvastatin Structural Formula (7f4945a8 B0a0 41ec 984c E2a34812bb8b 01)
FDA Label Image

Figure 1: Primary Endpoint (Recurrent Cardiac Events (Cardiac Death, Nonfatal MI or Revascularization Procedure) (ITT Population))

Figure 1: Primary Endpoint (Recurrent Cardiac Events (Cardiac Death, Nonfatal MI or Revascularization Procedure) (ITT Population))
FDA Label Image

Figure 2: Fluvastatin Capsules Intervention Prevention Study (Primary and Secondary Endpoints)

Figure 2: Fluvastatin Capsules Intervention Prevention Study (Primary and Secondary Endpoints)
FDA Label Image

Figure 3: Change In Minimum Lumen Diameter (mm) (7f4945a8 B0a0 41ec 984c E2a34812bb8b 04)

Figure 3: Change In Minimum Lumen Diameter (mm) (7f4945a8 B0a0 41ec 984c E2a34812bb8b 04)
FDA Label Image

Figure 4: Change In % Diameter Stenosis (7f4945a8 B0a0 41ec 984c E2a34812bb8b 05)

Figure 4: Change In % Diameter Stenosis (7f4945a8 B0a0 41ec 984c E2a34812bb8b 05)
This appears to be a graph or chart showing the change in diameter stenosis due to different therapies. The therapies include monotherapy with olsertamie and combination therapy with fluvastatin and/or CME. The results are shown as percentages, and there are statistical significance levels indicated (p-values). The graph shows that there is a decrease in diameter stenosis for all therapies, but the degree of decrease varies.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.